LncRNA TDRG1 promotes the aggressiveness of gastric carcinoma through regulating miR-873-5p/HDGF axis - 30/11/19
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
pages | 11 |
Iconographies | 9 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | LncRNAs TDRG1 is upregulated in clinical gastric carcinoma (GC). |
• | TDRG1 promotes GC cell growth and metastatic-related traits in vitro and in vivo. |
• | TDRG1 interacts with miR-873-5p and positively modulates the expression of HDGF. |
• | TDRG1 regulates the progression of GC through regulating miR-873-5p/HDGF pathway. |
Abstract |
Gastric carcinoma (GC) is still one of the most common digestive system neoplasms and the primary reason for malignant cancer-associated death. Long non-coding RNAs (lncRNAs) have been reported to play critical roles in GC progression. In this study, we demonstrated that lncRNA testis development-related gene 1 (TDRG1) is markedly upregulated in clinical GC tissues and GC cells. High level of lncRNA TDRG1 correlates with the metastasis and prognosis of patients with GC. Overexpression of lncRNA TDRG1 promotes GC growth and metastatic-related traits in vitro and in vivo, and silencing TDRG1 causes opposite results. We future find that TDRG1 is inversely associated with miR-873-5p and positively modulates the expression of hepatoma-derived growth factor (HDGF), a functional target gene of miR-873-5p. Finally, lncRNA TDRG1 regulates the progression of GC through regulating miR-873-5p/HDGF pathway. Taken together, our data uncover the crucial function of TDRG1-miR-873-5p-HDGF axis in human gastric cancer.
Le texte complet de cet article est disponible en PDF.Keywords : TDRG1, Gastric carcinoma, miR-873-5p, HDGF
Plan
Vol 121
Article 109425- janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?